Peroxisomal Biogenesis Factor 5-Like 抗体
(Peroxisomal Biogenesis Factor 5-Like (PEX5L))
plays a role in cAMP-induced ACTH secretion
Recommended next Filters:
33 results
PEX5L
适用: 大鼠, 小鼠, 人
IHC, WB, ELISA
宿主: 兔
Polyclonal
unconjugated
PEX5L
IHC, WB
宿主: 小鼠
Monoclonal
N212-17
unconjugated
Recombinant Antibody
KO Validated
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA
宿主: 小鼠
Monoclonal
N212-3
unconjugated
KO Validated
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA, IP
宿主: 小鼠
Monoclonal
N212-17
unconjugated
KO Validated
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA
宿主: 小鼠
Monoclonal
N212-7
unconjugated
KO Validated
PEX5L
适用: 大鼠
ICC, WB, ELISA
宿主: 小鼠
Monoclonal
N212A-34
unconjugated
KO Validated
PEX5L
适用: 小鼠
ICC, WB, ELISA
宿主: 小鼠
Monoclonal
N291C-22
unconjugated
Carrier-free
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA
宿主: 小鼠
Monoclonal
N212-3
unconjugated
KO Validated
PEX5L
适用: 大鼠
ICC, IHC
宿主: 小鼠
Monoclonal
N212-3
FL490
KO Validated
PEX5L
适用: 大鼠
ICC, IHC
宿主: 小鼠
Monoclonal
N212-3
FL550
KO Validated
PEX5L
适用: 大鼠
ICC, IHC
宿主: 小鼠
Monoclonal
N212-3
FL650
KO Validated
PEX5L
适用: 大鼠
ICC, IHC
宿主: 小鼠
Monoclonal
N212-3
FL594
Carrier-free
PEX5L
适用: 小鼠
ICC, WB, ELISA
宿主: 小鼠
Monoclonal
N291C-22
unconjugated
KO Validated
PEX5L
适用: 小鼠
ICC
宿主: 小鼠
Monoclonal
N291C-22
FL490
KO Validated
PEX5L
适用: 小鼠
ICC
宿主: 小鼠
Monoclonal
N291C-22
FL550
KO Validated
PEX5L
适用: 小鼠
ICC
宿主: 小鼠
Monoclonal
N291C-22
FL594
KO Validated
PEX5L
适用: 小鼠
ICC
宿主: 小鼠
Monoclonal
N291C-22
FL650
Carrier-free
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA
宿主: 小鼠
Monoclonal
N212-17
unconjugated
Carrier-free
PEX5L
适用: 大鼠
ICC, IHC, WB, ELISA
宿主: 小鼠
Monoclonal
N212-7
unconjugated
Latest Publications for our Peroxisomal Biogenesis Factor 5-Like 抗体
: "Imbalance of HCN1 and HCN2 expression in hippocampal CA1 area impairs spatial learning and memory in rats with chronic morphine exposure." in: Progress in neuro-psychopharmacology & biological psychiatry, Vol. 56, pp. 207-14, (2014) (PubMed).: "TRIP8b is required for maximal expression of HCN1 in the mouse retina." in: PLoS ONE, Vol. 9, Issue 1, pp. e85850, (2014) (PubMed).
: "Nedd4-2 regulates surface expression and may affect N-glycosylation of hyperpolarization-activated cyclic nucleotide-gated (HCN)-1 channels." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 28, Issue 5, pp. 2177-90, (2014) (PubMed).
: "Activation of GABAB receptors ameliorates cognitive impairment via restoring the balance of HCN1/HCN2 surface expression in the hippocampal CA1 area in rats with chronic cerebral hypoperfusion." in: Molecular neurobiology, Vol. 50, Issue 2, pp. 704-20, (2014) (PubMed).
: "Reelin signaling specifies the molecular identity of the pyramidal neuron distal dendritic compartment." in: Cell, Vol. 158, Issue 6, pp. 1335-47, (2014) (PubMed).
: "Up-regulation of hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain-containing protein 3 (KCTD3)." in: The Journal of biological chemistry, Vol. 288, Issue 11, pp. 7580-9, (2013) (PubMed).
: "Regulation of axonal HCN1 trafficking in perforant path involves expression of specific TRIP8b isoforms." in: PLoS ONE, Vol. 7, Issue 2, pp. e32181, (2012) (PubMed).
: "TRIP8b splice forms act in concert to regulate the localization and expression of HCN1 channels in CA1 pyramidal neurons." in: Neuron, Vol. 70, Issue 3, pp. 495-509, (2011) (PubMed).
Aliases for Peroxisomal Biogenesis Factor 5-Like 抗体
peroxisomal biogenesis factor 5 like (PEX5L) 抗体peroxisomal biogenesis factor 5-like (pex5l) 抗体
peroxisomal biogenesis factor 5-like (Pex5l) 抗体
1700016J08Rik 抗体
Pex2 抗体
PEX5R 抗体
PEX5RP 抗体
PXR2 抗体
PXR2B 抗体
TRIP8b 抗体
Trjip8b 抗体
您还需要查找其他产品吗？
- Peroxiredoxin 6 抗体
- Peroxiredoxin 5 抗体
- Peroxiredoxin 4 抗体
- Peroxiredoxin 3 抗体
- Peroxiredoxin 2 抗体
- Peroxiredoxin 1 抗体
- Peroxidasin 抗体
- Peroxidase 抗体
- Peropsin 抗体
- Permeability Glycoprotein 抗体
- PERK 抗体
- Peripherin 抗体
- Peripheral Myelin Protein 22 抗体
- Periostin 抗体
- Period Homolog 1 (Drosophila) 抗体
- Periaxin 抗体
- Perforin 1 抗体
- PER3 抗体
- PER2 抗体
- Peptidylprolyl Isomerase A (Cyclophilin A) 抗体
You are here:
